Skip to content

Combined Effects of Lion's Breath Technique With Chest Percussion Therapy in Pneumonia Patients

Combined Effects of Lion's Breath Technique With Chest Percussion Therapy in Pneumonia Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06319690
Enrollment
90
Registered
2024-03-20
Start date
2024-03-01
Completion date
2024-06-15
Last updated
2024-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia

Keywords

Breathing exercises, Lion's Breath Technique, Pulmonary rehabilitation

Brief summary

This study will be randomized controlled trial with non-probability convenient sampling. Sample size will be 90,45 in each group. Outcome will be measured by using 6 minute walk test, Spirometry (FVC, FEV1/FVC and PEF), Functional Independence Measure.

Detailed description

The main objective of the study is to determine the effect of lion's breath technique along with chest percussion therapy in pneumonia patients. This study will be randomized controlled trial with non-probability convenient sampling. Sample size will be 90,45 in each group. Participants included will be adults aged 18 years and above diagnosed with pneumonia. Willing to comply with the study protocol. Both male and female will be included. Participants should be in stable health conditions to participate in the Study. Patients with severe or life-threatening pneumonia requiring immediate intensive care and patients with physical or cognitive limitations. Patients with a history of chronic respiratory conditions such as COPD, bronchitis, or asthma. Pregnant or breastfeeding women. Individuals with musculoskeletal or neurological conditions and Patients with contraindications to chest percussion therapy, such as recent surgery or trauma to the chest area will be excluded. Group A (Lion's Breath Technique + Chest Percussion Therapy) Daily supervised Lion's Breath Technique sessions will be for 20 minutes for 1 week. Trained physiotherapists administer chest percussion therapy will be to mobilize secretions and improve lung function. Daily session for 30 minutes for 1 week. Pre and post data will be gathered. Outcome will be measured by using 6 minute walk test, Spirometry (FVC, FEV1/FVC and PEF), Functional Independence Measure.

Interventions

OTHERLion's Breath Technique

Patients receive training in Lion's Breath Technique, emphasizing deep diaphragmatic breathing and controlled exhalation. Daily supervised Lion's Breath Technique sessions for 20 minutes for 1 week

OTHERChest Percussion Therapy

Trained physiotherapists administer chest percussion therapy to mobilize secretions and improve lung function. Daily session for 30 minutes for 1 week.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Randomized Control Trial (RCT)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients in the post-acute phase of pneumonia recovery. * Adults aged 18 years and above diagnosed with pneumonia. * Both male and female will be included. * Participants should be in stable health conditions to participate in the Study. * Willing to comply with the study protocol

Exclusion criteria

* Patients with severe or life-threatening pneumonia requiring immediate intensive care * Patients with physical or cognitive limitations * Patients with a history of chronic respiratory conditions such as COPD, bronchitis, or asthma * Pregnant or breastfeeding women * Individuals with musculoskeletal or neurological conditions * Patients with contraindications to chest percussion therapy, such as recent surgery or trauma to the chest area

Design outcomes

Primary

MeasureTime frameDescription
George respiratory questionnaire1 WeekThe George respiratory questionnaire is Disease-specific instrument designed to measure the impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease. Total 50 items, 2 parts (3 components). Part 1 : Symptoms component (frequency & severity) with a 1, 3 or 12-month recall (best performance with 3- and 12-month recall); Part 2: Activities that cause or are limited by breathlessness; Impact components (social functioning, psychological disturbances resulting from airways disease) refer to current state as the recall. Part I (Symptoms): several scales; Part II (Activity and Impacts): dichotomous (true/false) except last question (4-point Likert scale) Scores range from 0 to 100, with higher scores indicating more limitations.
Forced vital capacity (FVC)1 WeekForced vital capacity (FVC) is the amount of air that can be forcibly exhaled from your lungs after taking the deepest breath possible. It's measured by spirometry
Borg Dyspnea Scale1 WeekThe borg dyspnea scale is a numerical scale that measures the intensity of breathlessness of fatigue. It will be used to assess the baseline and posttest symptoms of patients with respiratory and cardiac condition. This is a scale that asks you to rate the difficulty of your breathing. It starts at number 0 where your breathing is causing you no difficulty at all and progresses through to number 10 where your breathing difficulty is maximal
Forced expiratory volume (FEV1)1 WeekForced expiratory volume (FEV1) calculates the amount of air that a person can force out of their lungs in 1 second. it is measured using Spirometer.
FEV1/FVC Ratio1 WeekThe FEV1/FVC ratio is the ratio of the forced expiratory volume in the first one second to the forced vital capacity of the lungs. The normal value for this ratio is above 0.75-85, measured using Spirometer.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026